Last update :
05/12/2025
References   References 4086  
Type : Manufacturer

Research teams :
Authors :
Title : Octréotide - (Sandostatine®)- Résumé des caractéristiques du produit
Reference : Novartis Pharma 2017

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
injectionOctreotide acetate Various
Factors which affect stability Solvent Parenteral nutrition (with lipids) Induces Degradation
Compatible + Sodium chloride 0,9%
Compatible + Glucose 5%
Incompatible + Parenteral nutrition (with lipids)

  Mentions Légales